Skip to main content

Conventional measures underestimate glycaemia in cystic fibrosis patients

Buy Article:

$43.00 plus tax (Refund Policy)

Aims  Diabetes mellitus is an increasingly important complication of cystic fibrosis (CF). The association with increased morbidity of cystic fibrosis‐related diabetes (CFRD) has emphasized the need for accurate monitoring of glycaemia in all CF patients. The diagnosis has relied on conventional thresholds in an oral glucose tolerance test (OGTT) derived from epidemiological studies in non‐CF subjects. However, it has not been established if these values are equivalent in CF and non‐CF populations.
No References
No Citations
No Supplementary Data
No Article Media
No Metrics

Keywords: continuous glucose monitoring system; cystic fibrosis; cystic fibrosisā€related diabetes; glycosylated haemoglobin; oral glucose tolerance test

Document Type: Research Article

Affiliations: 1: Department of Respiratory Medicine, Royal Devon and Exeter Hospital and 2: Diabetes and Vascular Medicine, Peninsular Medical School, Exeter, UK

Publication date: 01 July 2004

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more